InterCure Ltd. Form 6-K Summary
Business context and reporting period
InterCure Ltd., an Israeli foreign private issuer, filed this Form 6-K on January 4, 2022, covering the month of January 2022. The filing contains one exhibit: a December 30, 2021 press release announcing the results of the company’s annual general meeting of shareholders.
Financial and operating metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material changes versus the prior comparable period
The filing text does not provide financial or operational comparisons with a prior period. It reports a shareholder meeting event rather than periodic financial results.
Guidance, outlook, risks, and unusual items
The filing text does not provide guidance, outlook commentary, risk disclosures, contingencies, or unusual financial items. The underlying exhibit concerns the results of the annual general meeting, but the specific resolutions and voting outcomes are not included in the provided filing text.
Investor verification points
- Review Exhibit 99.1 for the detailed annual general meeting resolutions and voting results.
- Confirm whether any director elections, auditor appointments, compensation matters, or other shareholder approvals were addressed.
- Consult the company’s applicable annual report or other filings for financial results, liquidity, debt, and forward-looking information.